Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dror Ortho-Design, Inc.DROR · Entity 8012 | Director | August 14, 2023 | September 27, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dror Ortho-Design, Inc.
Report date August 14, 2023 · Filed September 27, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 | Direct | 2,150,945.54 |
Reported balance
After 2023-08-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-08-14 · Grant · Acquired 2,150,945.54 · Balance 2,150,945.54 F3: Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, the reporting person transferred 58,493 ordinary shares of Private Dror, representing all ordinary shares of Private Dror held by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange"). F1: Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock. F2: The Preferred Stock is perpetual and therefore has no expiration date. |
| Common WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.03 | Direct | 228,251,826 |
Reported balance
After 2023-08-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-08-14 · Grant · Acquired 228,251,826 · Balance 228,251,826 F6: Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 62,071 ordinary shares of Private Dror, representing all warrants to purchase ordinary shares of Private Dror held by the reporting person, were cancelled, and the Company issued to the reporting person warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share (the "Warrant Exchange"). F4: Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date"). F5: Warrants expire on the fifth anniversary of the Initial Exercise Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock.
F2: The Preferred Stock is perpetual and therefore has no expiration date.
F3: Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, the reporting person transferred 58,493 ordinary shares of Private Dror, representing all ordinary shares of Private Dror held by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange").
F4: Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date").
F5: Warrants expire on the fifth anniversary of the Initial Exercise Date.
F6: Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 62,071 ordinary shares of Private Dror, representing all warrants to purchase ordinary shares of Private Dror held by the reporting person, were cancelled, and the Company issued to the reporting person warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share (the "Warrant Exchange").
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2023 Filed Sep 27, 2023 21:32 UTC | Dror Ortho-Design, Inc. DROR · Entity 8012 | GrantCommon Warrants · Derivative | 228,251,826 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001387131-23-011681 · ravad_form4-092723.xml · derivative · entry 2 Ravad Chaim · CIK 0001993628 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,251,826 Underlying: Common Stock · 228,251,826 shares Expires not disclosed F6 · price: Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 62,071 ordinary shares of Private Dror, representing all warrants to purchase ordinary shares of Private Dror held by the reporting person, were cancelled, and the Company issued to the reporting person warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share (the "Warrant Exchange"). F4 · derivative.exercise_date: Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date"). F5 · derivative.expiration_date: Warrants expire on the fifth anniversary of the Initial Exercise Date. Read SEC document |
| August 14, 2023 Filed Sep 27, 2023 21:32 UTC | Dror Ortho-Design, Inc. DROR · Entity 8012 | GrantSeries A Convertible Preferred Stock · Derivative | 2,150,945.54 | Not disclosed Strike: $0.01 | Not disclosed |
DisclosureSEC source: 0001387131-23-011681 · ravad_form4-092723.xml · derivative · entry 1 Ravad Chaim · CIK 0001993628 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,150,945.54 Underlying: Common Stock · 215,094,554 shares Expires not disclosed F3 · price: Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, the reporting person transferred 58,493 ordinary shares of Private Dror, representing all ordinary shares of Private Dror held by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange"). F1 · derivative.exercise_date: Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock. F2 · derivative.expiration_date: The Preferred Stock is perpetual and therefore has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.